The family of the first man to die of Ebola in the U.S. is speaking out, saying Thomas Eric Duncan's "was treated unfairly."
In an exclusive statement to OutFront, Josephus Weeks, Duncan's nephew, says:
"Eric Duncan was treated unfairly. Eric walked into the hospital, the other patients were carried in after an 18 hour flight.
It is suspicious to us that all the white patients survived and this one black patient passed away.
It took 8 days to get him medicine. He didn't begin treatment in Africa, he began treatment here, but he wasn't given a chance.
We need all the help we can get, no matter how small it is. All would be accepted and would be highly appreciated."
Texas Health Presbyterian Hospital in Dallas, which treated Thomas Eric Duncan, also put out a statement saying, in part:
"Mr. Duncan’s physicians treated him with the most appropriate and available medical interventions, including the investigative antiviral drug Brincidofovir. Mr. Duncan was the first Ebola patient to receive this drug.
Mr. Duncan did not receive the same type of serum transfusion as the patient in Nebraska because his blood type was not compatible with the serum donors.
A team of more than 50 people cared for him in a professional and compassionate manner.
Our care team provided Mr. Duncan with the same high level of attention and care that would be given any patient, regardless of nationality or ability to pay for care. We have a long history of treating a multicultural community in this area."
Did race play a factor in Duncan's treatment? Ed Lavandera is OutFront.
Also weighing in:CNN's Chief Medical correspondent, Dr. Sanjay Gupta, and Dr. Ivan Walks, The Former District Of Columbia Chief Medical Officer.